JP2009203190A - Cell activator and anti-aging skin preparation for external use - Google Patents
Cell activator and anti-aging skin preparation for external use Download PDFInfo
- Publication number
- JP2009203190A JP2009203190A JP2008047445A JP2008047445A JP2009203190A JP 2009203190 A JP2009203190 A JP 2009203190A JP 2008047445 A JP2008047445 A JP 2008047445A JP 2008047445 A JP2008047445 A JP 2008047445A JP 2009203190 A JP2009203190 A JP 2009203190A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- cell activator
- skin
- acid
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012190 activator Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 11
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical class OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 42
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 11
- 239000008347 soybean phospholipid Substances 0.000 claims description 9
- SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 claims description 8
- 239000000284 extract Substances 0.000 description 75
- 210000004027 cell Anatomy 0.000 description 23
- 230000020411 cell activation Effects 0.000 description 14
- 239000006071 cream Substances 0.000 description 14
- -1 dipalmitoyl phosphatidylinositol sodium salt Chemical class 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 11
- 239000008213 purified water Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 229940075507 glyceryl monostearate Drugs 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000020176 deacylation Effects 0.000 description 4
- 238000005947 deacylation reaction Methods 0.000 description 4
- 239000008344 egg yolk phospholipid Substances 0.000 description 4
- 229940068998 egg yolk phospholipid Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 4
- 150000003905 phosphatidylinositols Chemical class 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 235000020221 chamomile extract Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 240000000982 Malva neglecta Species 0.000 description 2
- 235000000060 Malva neglecta Nutrition 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229940123973 Oxygen scavenger Drugs 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- AFINAILKDBCXMX-PBHICJAKSA-N (2s,3r)-2-amino-3-hydroxy-n-(4-octylphenyl)butanamide Chemical compound CCCCCCCCC1=CC=C(NC(=O)[C@@H](N)[C@@H](C)O)C=C1 AFINAILKDBCXMX-PBHICJAKSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SLKDGVPOSSLUAI-PGUFJCEWSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC SLKDGVPOSSLUAI-PGUFJCEWSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- HIPQTCQUXOFTFI-UHFFFAOYSA-N 2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)C(=O)C1=CC=CC=C1 HIPQTCQUXOFTFI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241001316290 Gypsophila Species 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229940069774 quince extract Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、新規な細胞賦活剤及び老化防止用皮膚外用剤に関する。 The present invention relates to a novel cell activator and an anti-aging skin external preparation.
大豆リン脂質等のリン脂質は、化粧料等の皮膚外用剤の基剤として汎用されている。しかし、これを脱アシル化したグリセロールリン酸誘導体については、従来、その用途があまり知られていない。特許文献1及び2には、グリセロールリン酸塩やその誘導体等を、皮膚外用剤に利用することが提案されている。しかし、これらの特許文献には、これらの剤の細胞賦活作用についての記載はない。
本発明は、新規な細胞賦活剤及び老化防止用皮膚外用剤を提供することを課題とする。 An object of the present invention is to provide a novel cell activator and an anti-aging skin external preparation.
本発明は、前記課題を解決するため、グリセロールリン酸誘導体の少なくとも一種を有効成分とする細胞賦活剤、及びこれを有効成分として含有する老化防止用皮膚外用剤を提供する。
グリセロールリン酸誘導体の中でも、グリセロールホスホリルエタノールアミン、グリセロールホスホリルイノシトールが好ましい。また、グリセロール誘導体、好ましくはグリセロールホスホリルエタノールアミン及びグリセロールホスホリルイノシトールは、大豆リン脂質の脱アシル化物であるのが好ましい。
In order to solve the above-mentioned problems, the present invention provides a cell activator containing at least one glycerol phosphate derivative as an active ingredient, and an anti-aging skin external preparation containing this as an active ingredient.
Among the glycerol phosphate derivatives, glycerol phosphorylethanolamine and glycerol phosphoryl inositol are preferable. Also, the glycerol derivatives, preferably glycerol phosphorylethanolamine and glycerol phosphoryl inositol are preferably deacylated products of soybean phospholipid.
本発明によれば、良好な細胞賦活作用を示す新規な細胞賦活剤、及び該細胞賦活剤によってもたらされる良好な老化防止効果を奏する皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the novel cell activator which shows a favorable cell activation effect | action, and the skin external preparation which shows the favorable anti-aging effect brought about by this cell activator can be provided.
以下、本発明について詳細に説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。
本発明は、グリセロールリン酸誘導体の少なくとも一種を有効成分とする細胞賦活剤に関する。本発明の細胞賦活剤は、一種のグリセロールリン酸誘導体を有効成分とするものであってもよいし、異なる二種以上のグリセロールリン酸誘導体を有効成分とするものであってもよい。本明細書では、「グリセロールリン酸誘導体」とは、グリセリンの3つの水酸基の水素原子のいずれかが、リン酸誘導体によって置換された化合物をいうものとする。その例には、グリセロールホスリルコリン(以下、「GPC」という場合がある)、グリセロールホスホリルエタノールアミン(以下、「GPE」という場合がある)、及びグリセロールホスホリルイノシトール(以下、「GPI」という場合がある)が含まれる。GPC、GPE及びGPIはそれぞれ、以下の一般式で表される化合物である。
Hereinafter, the present invention will be described in detail. In the present specification, “to” means a range including numerical values before and after.
The present invention relates to a cell activator comprising at least one glycerol phosphate derivative as an active ingredient. The cell activator of the present invention may contain one kind of glycerol phosphate derivative as an active ingredient, or may contain two or more different glycerol phosphate derivatives as an active ingredient. In the present specification, the “glycerol phosphate derivative” refers to a compound in which any of the hydrogen atoms of three hydroxyl groups of glycerin is substituted with a phosphate derivative. Examples thereof include glycerol phosphorylcholine (hereinafter sometimes referred to as “GPC”), glycerol phosphorylethanolamine (hereinafter sometimes referred to as “GPE”), and glycerol phosphorylinositol (hereinafter referred to as “GPI”). Is included). GPC, GPE and GPI are each a compound represented by the following general formula.
これらの化合物は、大豆リン脂質及び卵黄リン脂質の成分である、フォスファチルジルコリン(PC)、フォスファチジルエタノールアミン(PE)及びフォスファチジルイノシトール(PI)の、分子中のアシル基をそれぞれ、脱アシル化した構造を有する。
本発明に使用するこれらの化合物の合成方法については特に制限されるものではない。リン脂質を脱アシル化して得られる化合物、及び脱アシル化工程を経ずに、化学合成によって得られる化合物のいずれも用いることができる。
These compounds contain acyl groups in the molecule of phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylinositol (PI), which are components of soybean phospholipid and egg yolk phospholipid. Each has a deacylated structure.
The method for synthesizing these compounds used in the present invention is not particularly limited. Any of a compound obtained by deacylating a phospholipid and a compound obtained by chemical synthesis without passing through the deacylation step can be used.
例えば、卵黄リン脂質や大豆リン脂質は、上記PC、PE及びPIを含有するので、卵黄リン脂質や大豆リン脂質を脱アシル化処理することで、本発明の細胞賦活剤を調製することができる。また、卵黄リン脂質や大豆リン脂質を脱アシル化処理した後、クロマトグラムなどでGPC、GPE及びGPIをそれぞれ単離し、単離された各化合物を用いることもできる。また、本発明の細胞賦活剤には、化学合成したGPC、GPE及びGPIを用いることもできる。GPCは試薬として市販されている(例えば和光純薬社製)ので、該試薬をそのまま、又はGPEやGPIと混合して、本発明の細胞賦活剤を調製することができる。また、GPEやGPIは、グリセロールに脂肪酸及び対応するリン酸誘導体が結合した試薬(例えば、ジパルミトイルホスファジルエタノールアミン(和光純薬製)及びジパルミトイルホスファチジルイノシトール・ナトリウム塩(和光純薬製))が市販されているので、それらを脱アシル化すること等で、それぞれ合成することができる。 For example, since egg yolk phospholipid and soybean phospholipid contain PC, PE, and PI, the cell activator of the present invention can be prepared by deacylating egg yolk phospholipid or soybean phospholipid. . In addition, after egg yolk phospholipid or soybean phospholipid is deacylated, GPC, GPE and GPI are isolated by chromatogram or the like, and the isolated compounds can be used. Moreover, chemically synthesized GPC, GPE and GPI can also be used for the cell activator of the present invention. Since GPC is commercially available as a reagent (for example, manufactured by Wako Pure Chemical Industries, Ltd.), the cell activator of the present invention can be prepared by mixing the reagent as it is or with GPE or GPI. GPE or GPI is a reagent in which a fatty acid and a corresponding phosphoric acid derivative are bound to glycerol (for example, dipalmitoyl phosphatidylethanolamine (manufactured by Wako Pure Chemical Industries) and dipalmitoyl phosphatidylinositol sodium salt (manufactured by Wako Pure Chemical Industries)) Are commercially available, and can be synthesized by deacylating them.
グリセロールリン酸誘導体の中でも、GPE及びGPIが、細胞賦活作用が高いので好ましい。本発明の細胞賦活剤は、GPE及びGPIのうち少なくとも一種を有効成分として含有するのが好ましい。より具体的には、本発明の細胞賦活剤は、GPE及び/又はGPIを質量割合で30%以上含有するのが好ましい。大豆リン脂質は、PE及びPIをそれぞれ14質量%程度及び17質量%程度含有する。したがって、大豆リン脂質を脱アシル化処理して調製された細胞賦活剤は、GPE及びGPIを総量として約31質量%含有しているので、高い細胞賦活作用を示すと考えられる。 Among the glycerol phosphate derivatives, GPE and GPI are preferable because of their high cell activation effect. The cell activator of the present invention preferably contains at least one of GPE and GPI as an active ingredient. More specifically, the cell activator of the present invention preferably contains GPE and / or GPI at a mass ratio of 30% or more. Soy phospholipid contains about 14% by mass and 17% by mass of PE and PI, respectively. Therefore, the cell activator prepared by deacylating soybean phospholipid contains GPE and GPI in a total amount of about 31% by mass, and is considered to exhibit a high cell activation effect.
本発明は、本発明の細胞賦活剤、すなわちグリセロールリン酸誘導体から選ばれる少なくとも一種を有効成分とする細胞賦活剤、を含有する皮膚外用剤にも関する。本発明の皮膚外用剤は、グリセロールリン酸誘導体の細胞賦活作用によって、優れた老化防止効果を奏する。本発明の皮膚外用剤中の前記細胞賦活剤の含有量は、好ましくは0.0001〜20質量%(以下単に「%」で示す)であり、より好ましくは0.001〜10%である。この範囲内であれば、前記抽出物を安定に配合することができ、かつ高い老化防止効果を発揮することができる。 The present invention also relates to a skin external preparation containing the cell activator of the present invention, that is, a cell activator containing as an active ingredient at least one selected from glycerol phosphate derivatives. The external preparation for skin of the present invention exhibits an excellent anti-aging effect by the cell activation action of a glycerol phosphate derivative. The content of the cell activator in the external preparation for skin of the present invention is preferably 0.0001 to 20% by mass (hereinafter simply referred to as “%”), more preferably 0.001 to 10%. If it exists in this range, the said extract can be mix | blended stably and the high anti-aging effect can be exhibited.
本発明の皮膚外用剤は、前記細胞賦活剤を常法に従い、種々の形態の基剤に配合して製剤化することにより調製できる。更に、前記細胞賦活剤を他の薬効剤の一種又は二種以上と組み合わせて配合することによって、細胞賦活効果をより高めた、もしくは細胞賦活効果とともに他の薬効も奏する皮膚外用剤を調製することができる。他の薬効剤の例には、美白剤、紫外線防御剤、抗菌剤、抗炎症剤、他の細胞賦活剤、活性酸素除去剤、及び保湿剤などが含まれるが、これらに限定されることはない。 The external preparation for skin of the present invention can be prepared by formulating the cell activator by blending it with various forms of bases according to a conventional method. Furthermore, by preparing the above-mentioned cell activator in combination with one or more other medicinal agents, the cell activation effect is further enhanced, or a skin external preparation that exhibits other medicinal effects together with the cell activation effect is prepared. Can do. Examples of other medicinal agents include, but are not limited to, whitening agents, UV protection agents, antibacterial agents, anti-inflammatory agents, other cell activators, active oxygen scavengers, and moisturizers. Absent.
美白剤の例には、アスコルビン酸又はその誘導体、アルブチン、エラグ酸、リノール酸、ビタミンE及びその誘導体、グリチルリチン酸及びその誘導体、トラネキサム酸、胎盤抽出物、カミツレ抽出物、カンゾウ抽出物、エイジツ抽出物、オウゴン抽出物、海藻抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、コメヌカ抽出物、小麦胚芽抽出物、サイシン抽出物、サンザシ抽出物、サンペンズ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、大豆抽出物、茶抽出物、糖蜜抽出物、ビャクレン抽出物、ブドウ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物、ユキノシタ抽出物等が含まれる。 Examples of whitening agents include ascorbic acid or derivatives thereof, arbutin, ellagic acid, linoleic acid, vitamin E and derivatives thereof, glycyrrhizic acid and derivatives thereof, tranexamic acid, placenta extract, chamomile extract, licorice extract, age extract , Ogon extract, seaweed extract, cucumber extract, caquette extract, gokahi extract, rice bran extract, wheat germ extract, saicin extract, hawthorn extract, sun penz extract, shirayuri extract, peony extract Sempukuka extract, soybean extract, tea extract, molasses extract, sandalwood extract, grape extract, hop extract, micaika extract, mokka extract, yukinoshita extract and the like.
紫外線防御剤としては、例えば、パラメトキシケイ皮酸−2−エチルヘキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸ナトリウム、4−t−ブチル−4’−メトキシジベンゾイルメタン、2−フェニル−ベンズイミダゾール−5−硫酸、酸化チタン、酸化亜鉛等が挙げられる。 Examples of the UV protection agent include paramethoxycinnamate-2-ethylhexyl, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5 sodium sulfate, 4-t-butyl-4′- Examples thereof include methoxydibenzoylmethane, 2-phenyl-benzimidazole-5-sulfuric acid, titanium oxide, and zinc oxide.
抗菌剤としては、例えば、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。 Examples of the antibacterial agent include benzoic acid, sodium benzoate, p-hydroxybenzoate ester, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol, and the like.
抗炎症剤としては、例えば、イオウ及びその誘導体、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、アルテア抽出物、アシタバ抽出物、アルニカ抽出物、インチンコウ抽出物、イラクサ抽出物、オウバク抽出物、オトギリソウ抽出物、カミツレ抽出物、キンギンカ抽出物、クレソン抽出物、コンフリー抽出物、サルビア抽出物、シコン抽出物、シソ抽出物、シラカバ抽出物、ゲンチアナ抽出物等が挙げられる。 Anti-inflammatory agents include, for example, sulfur and its derivatives, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, artea extract, ashitaba extract, arnica extract, ginseng extract, nettle extract, buckwheat extract, hypericum Examples include extracts, chamomile extracts, goldfish extract, watercress extract, comfrey extract, salvia extract, sicon extract, perilla extract, birch extract, gentian extract and the like.
他の細胞賦活剤の例には、カフェイン、鶏冠抽出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ラクトフェリン又はその分解物、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類またはそれらの塩、コラーゲン、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物、醗酵代謝抽出物、イチョウ抽出物、オオムギ抽出物、センブリ抽出物、タイソウ抽出物、ニンジン抽出物、ローズマリー抽出物、グリコール酸、クエン酸、乳酸、リンゴ酸、酒石酸、コハク酸等が含まれる。 Examples of other cell activators include caffeine, chicken crown extract, shell extract, shell extract, royal jelly, silk protein and its degradation product or derivatives thereof, lactoferrin or its degradation product, chondroitin sulfate, hyaluronic acid Mucopolysaccharides or their salts, collagen, yeast extract, lactic acid bacteria extract, bifidobacteria extract, fermentation metabolic extract, ginkgo extract, barley extract, assembly extract, diatom extract, carrot extract, Rosemary extract, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, succinic acid and the like are included.
活性酸素除去剤は、過酸化脂質生成抑制等の作用を有しており、例えば、スーパーオキサイドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、ルチン及びその誘導体、ボタンピ抽出物、ヤシャジツ抽出物、メリッサ抽出物、羅漢果抽出物、レチノール及びその誘導体、カロチノイド等のビタミンA類、チアミンおよびその誘導体、リボフラビンおよびその誘導体、ピリドキシンおよびその誘導体、ニコチン酸およびその誘導体等のビタミンB類、トコフェロール及びその誘導体等のビタミンE類、ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が挙げられる。 The active oxygen scavenger has an action such as suppression of lipid peroxide production. For example, superoxide dismutase, mannitol, quercetin, catechin and derivatives thereof, rutin and derivatives thereof, button pi extract, yashajitsu extract, melissa extract , Lanahan fruit extract, retinol and its derivatives, vitamin A such as carotenoid, thiamine and its derivative, riboflavin and its derivative, pyridoxine and its derivative, vitamin B such as nicotinic acid and its derivative, tocopherol and its derivative, etc. Vitamin E, dibutylhydroxytoluene, butylhydroxyanisole, etc. are mentioned.
保湿剤としては、例えば、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解物並びにそれらの塩、グリシン、セリン、アスパラギン酸、グルタミン酸、アルギニン、テアニン等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、尿素、リン脂質、セラミド、オウレン抽出物、ショウブ抽出物、ジオウ抽出物、センキュウ抽出物、ゼニアオイ抽出物、タチジャコウソウ抽出物、ドクダミ抽出物、ハマメリス抽出物、ボダイジュ抽出物、マロニエ抽出物、マルメロ抽出物等が挙げられる。 Examples of the humectant include proteins such as elastin and keratin or derivatives thereof, hydrolysates and salts thereof, amino acids such as glycine, serine, aspartic acid, glutamic acid, arginine and theanine and derivatives thereof, sorbitol, erythritol, Trehalose, inositol, glucose, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-panthenol and derivatives thereof, urea, phospholipid, ceramide, auren extract, ginger extract, diautum extract, sensyu extract Product, mallow extract, gypsophila extract, dokudami extract, hamamelis extract, bodaige extract, maronier extract, quince extract and the like.
また、本発明の皮膚外用剤には、本発明の細胞賦活剤以外の任意の成分を配合することができる。そのような成分としては、例えば、アミノ酸、脂質、糖、ホルモン、酵素、核酸などの生理活性物質等を挙げることができるが、これらに限定されることはない。また、本発明の効果を損なわない範囲で、化粧料や医薬部外品、皮膚外用剤等の製造に通常使用される成分、例えば、水(精製水、温泉水、深層水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、香料、消臭剤、塩類、pH調整剤、清涼剤、植物・動物・微生物由来の抽出物、血行促進剤、収斂剤、抗脂漏剤、キレート剤、角質溶解剤、酵素、ホルモン類、他のビタミン類等を必要に応じて用いることができる。 Moreover, arbitrary components other than the cell activator of this invention can be mix | blended with the skin external preparation of this invention. Examples of such components include, but are not limited to, physiologically active substances such as amino acids, lipids, sugars, hormones, enzymes, and nucleic acids. In addition, components that are usually used in the production of cosmetics, quasi-drugs, skin external preparations and the like, for example, water (purified water, hot spring water, deep water, etc.), oil agents, Surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, film-forming agent, resin, inclusion compound, fragrance, deodorant, salt, pH adjuster, refreshing agent, plant / animal -Extracts derived from microorganisms, blood circulation promoters, astringents, antiseborrheic agents, chelating agents, keratolytic agents, enzymes, hormones, other vitamins and the like can be used as necessary.
本発明の皮膚外用剤は、パウダー、パウダーファンデーション等の粉体;石けん、リップスティック等の固体;クリーム、乳液、クリームファンデーション等の乳化物;化粧水、美容液等の液体;など、種々の形態の化粧料組成物であるのが好ましい。但し、これらに限定されるものではない。 The external preparation for skin of the present invention has various forms such as powders such as powder and powder foundation; solids such as soap and lipstick; emulsions such as cream, emulsion and cream foundation; It is preferable that it is a cosmetic composition. However, it is not limited to these.
以下に実施例を挙げて本発明を更に具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。
[例1:細胞賦活剤の調製]
GPCとして和光純薬製の試薬を用いた。
GPE、GPIについては、それぞれ、市販されているジパルミトイルホスファジルエタノールアミン(和光純薬製)、ジパルミトイルホスファチジルイノシトール・ナトリウム塩(和光純薬製)を脱アシル化処理することで製造した。脱アシル化は、アルコール中で金属ナトリウム又はナトリウムアルコラートを作用させることで進行させた。また、同様な方法により大豆リン脂質を脱アシル化処理したもの(以下、GSPという場合がある)も製造した。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to the following examples.
[Example 1: Preparation of cell activator]
A reagent manufactured by Wako Pure Chemical Industries was used as GPC.
GPE and GPI were produced by subjecting commercially available dipalmitoyl phosphadylethanolamine (manufactured by Wako Pure Chemical Industries) and dipalmitoyl phosphatidylinositol sodium salt (manufactured by Wako Pure Chemical Industries) to deacylation treatment, respectively. Deacylation proceeded by the action of metal sodium or sodium alcoholate in alcohol. In addition, a product obtained by subjecting soybean phospholipid to a deacylation process (hereinafter sometimes referred to as GSP) by a similar method was also produced.
[例2:細胞培養による細胞賦活試験]
GPE及びGPIについて、下記の方法により細胞賦活試験を行なった。
具体的には、1%ウシ胎児血清(FBS)添加培地に、下記表に示す濃度でGPE及びGPIをそれぞれ添加し、細胞生育率を常法により求めた。
試料未添加の1%FBS培地における細胞生育率を基準として、それより細胞生育率が上回った場合は、細胞賦活作用があり、下回った場合は、細胞賦活作用がないと評価することができる。
なお、10%FBS添加培地を陽性コントロールとして利用した。
以下の表に結果を示す。下記表に示す結果は、試料未添加の1%FBS培地の細胞生育率を100%として算出した各試料の細胞生育率である。
[Example 2: Cell activation test by cell culture]
About GPE and GPI, the cell activation test was done by the following method.
Specifically, GPE and GPI were respectively added to 1% fetal bovine serum (FBS) -added medium at the concentrations shown in the following table, and the cell growth rate was determined by a conventional method.
Based on the cell growth rate in the 1% FBS medium to which the sample is not added, when the cell growth rate is higher than that, there is a cell activation effect, and when it is lower, it can be evaluated that there is no cell activation effect.
A medium supplemented with 10% FBS was used as a positive control.
The results are shown in the following table. The results shown in the following table are the cell growth rates of the respective samples calculated with the cell growth rate of the 1% FBS medium not added with the sample as 100%.
上記表に示す結果から、グリセロールリン酸誘導体であるGPE及びGPIは、高い細胞賦活作用を示すことが理解できる。なお、GPCについても同様に試験を行ったが、細胞賦活作用が認められたものの、GPE及びGPIと比較して、その細胞賦活作用は低かった。 From the results shown in the above table, it can be understood that GPE and GPI, which are glycerol phosphate derivatives, show a high cell activation effect. In addition, although the test was done similarly about GPC, although the cell activation effect was recognized, the cell activation effect was low compared with GPE and GPI.
[例3:化粧水]
以下の製法で化粧水を調製した。
(製法)
A.下記成分(1)〜(11)を混合溶解する。
B.下記成分(12)〜(18)を混合溶解する。
C.AにBを加え均一に混合して化粧水を得た。
(成分) (%)
(1)グリセリン 3.0
(2)1,3−ブチレングリコール 2.0
(3)プロピレングリコール 4.0
(4)オレイルアルコール 0.1
(5)モノラウリン酸ポリオキシエチレン(20E.O.)
ソルビタン 1.5
(6)ポリオキシエチレン(20E.O.)ラウリル
エーテル 0.5
(7)スクワラン 0.5
(8)エチルアルコール 20.0
(9)パラオキシ安息香酸メチル 0.1
(10)酢酸dl−α−トコフェロール*1 0.5
(11)香料 適量
(12)グリチルリチン酸ジカリウム*2 0.5
(13)ローズマリー抽出物*3 0.5
(14)dl−ピロリドンカルボン酸ナトリウム*4 0.2
(15)ローカストビーンガム 1.0
(16)ヨクイニン抽出物*5 0.5
(17)GPE*6 0.5
(18)精製水 残量
*1 エーザイ社製
*2 丸善製薬社製
*3 丸善製薬社製
*4 味の素社製
*5 丸善製薬社製
*6 例1で調製したもの
[Example 3: lotion]
A lotion was prepared by the following production method.
(Manufacturing method)
A. The following components (1) to (11) are mixed and dissolved.
B. The following components (12) to (18) are mixed and dissolved.
C. B was added to A and mixed uniformly to obtain a skin lotion.
(Ingredient) (%)
(1) Glycerol 3.0
(2) 1,3-butylene glycol 2.0
(3) Propylene glycol 4.0
(4) Oleyl alcohol 0.1
(5) Polyoxyethylene monolaurate (20E.O.)
Sorbitan 1.5
(6) Polyoxyethylene (20E.O.) lauryl ether 0.5
(7) Squalane 0.5
(8) Ethyl alcohol 20.0
(9) Methyl paraoxybenzoate 0.1
(10) dl-α-tocopherol acetate * 1 0.5
(11) Perfume appropriate amount (12) Dipotassium glycyrrhizinate * 2 0.5
(13) Rosemary extract * 3 0.5
(14) Sodium dl-pyrrolidonecarboxylate * 4 0.2
(15) Locust bean gum 1.0
(16) Yokuinin extract * 5 0.5
(17) GPE * 6 0.5
(18) Purified water remaining * 1 Eisai * 2 Maruzen Pharmaceutical * 3 Maruzen Pharmaceutical * 4 Ajinomoto * 5 Maruzen * 6 Prepared in Example 1
調製した化粧水は、みずみずしくさっぱりとした使用感を有し、肌荒れや肌のくすみなどがない美しい肌とすることができる化粧水であった。 The prepared lotion was a lotion that had a fresh and refreshing feeling of use, and was able to provide beautiful skin without rough skin or dull skin.
[例4:クリーム]
下記の方法によりクレームを調製した。
(製法)
A.下記成分(1)〜(10)を加熱混合し、70℃に保つ。
B.下記成分(11)〜(21)を加熱混合し、70℃に保つ。
C.AにBを加えて乳化する。
D.Cを冷却後、下記成分(22)を加えて混合しクリームを得た。
(成分) (%)
(1)スクワラン 20.0
(2)ミツロウ 5.0
(3)ホホバ油 5.0
(4)モノステアリン酸グリセリル 2.0
(5)モノステアリン酸ポリオキシエチレン(20E.O.)
ソルビタン 2.0
(6)モノステアリン酸ソルビタン 2.0
(7)フィトステロール*1 0.5
(8)キャンデリラロウ 1.0
(9)グリセリン 5.0
(10)パラオキシ安息香酸メチル 0.1
(11)ユリ抽出物*2 1.0
(12)ニンジン抽出物*3 1.0
(13)イチョウ抽出物*4 1.0
(14)タイソウ抽出物*5 1.0
(15)クララ抽出物*6 1.0
(16)加水分解米抽出物*7 1.0
(17)甘草抽出物*8 1.0
(18)トウキ抽出物*9 1.0
(19)GPI*10 0.1
(20)GPE*11 0.1
(21)精製水 残量
(22)香料 適量
*1 エーザイ社製
*2 丸善製薬社製
*3 丸善製薬社製
*4 常磐植物化学研究所社製
*5 丸善製薬社製
*6 丸善製薬社製
*7 テクノーブル社製
*8 丸善製薬社製
*9 日本粉末薬品社製
*10 例1で調製したもの
*11 例1で調製したもの
[Example 4: Cream]
Claims were prepared by the following method.
(Manufacturing method)
A. The following components (1) to (10) are heated and mixed and maintained at 70 ° C.
B. The following components (11) to (21) are heated and mixed and maintained at 70 ° C.
C. B is added to A and emulsified.
D. After cooling C, the following component (22) was added and mixed to obtain a cream.
(Ingredient) (%)
(1) Squalane 20.0
(2) Beeswax 5.0
(3) Jojoba oil 5.0
(4) Glyceryl monostearate 2.0
(5) Polyoxyethylene monostearate (20E.O.)
Sorbitan 2.0
(6) Sorbitan monostearate 2.0
(7) Phytosterol * 1 0.5
(8) Candelilla wax 1.0
(9) Glycerin 5.0
(10) Methyl paraoxybenzoate 0.1
(11) Lily extract * 2 1.0
(12) Carrot extract * 3 1.0
(13) Ginkgo biloba extract * 4 1.0
(14) Isolate extract * 5 1.0
(15) Clara extract * 6 1.0
(16) Hydrolyzed rice extract * 7 1.0
(17) Licorice extract * 8 1.0
(18) Toki extract * 9 1.0
(19) GPI * 10 0.1
(20) GPE * 11 0.1
(21) Purified water Remaining amount (22) Fragrance Appropriate amount * 1 Eisai * 2 Maruzen Pharmaceutical * 3 Maruzen Pharmaceutical * 4 Joban Plant Chemical Research * 5 Maruzen * 6 Maruzen * 7 Made by Technoble * 8 Made by Maruzen Pharmaceutical Co., Ltd. * 9 Made by Nippon Powder Chemical Co., Ltd. * 10 Prepared by Example 1 * 11 Prepared by Example 1
調製したクリームは、滑らかでコクのある使用感を有し、肌荒れや肌のくすみなどがない美しい肌とすることができるクリームであった。 The prepared cream had a smooth and rich feeling of use, and was a cream that can be made into beautiful skin without rough skin or dull skin.
[例5:クレンジングクリーム]
以下の方法でクレンジングクリームを調製した。
(製法)
A.下記成分(1)〜(9)を加熱混合し、70℃に保つ。
B.下記成分(10)〜(14)を加熱混合し、70℃に保つ。
C.AにBを加えて乳化する。
D.Cを冷却後、下記成分(15)を加えて混合しクレンジングクリームを得た。
(成分) (%)
(1)パラフィンワックス 10.0
(2)ミツロウ 3.0
(3)ワセリン 15.0
(4)流動パラフィン 41.0
(5)セスキオレイン酸ソルビタン 4.2
(6)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.8
(7)水素添加大豆リン脂質 0.5
(8)メドゥホーム油*1 1.0
(9)パラオキシ安息香酸メチル 0.1
(10)クインスシード抽出物*2 1.0
(11)サボンソウ抽出物*3 1.0
(12)ゼニアオイ抽出物*4 1.0
(13)GSP*5 1.0
(14)精製水 残量
(15)香料 適量
*1 日本サーファクタント社製
*2 香栄興業社製
*3 丸善製薬社製
*4 丸善製薬社製
*5 例1で調製したもの
[Example 5: Cleansing cream]
A cleansing cream was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (9) are heated and mixed and maintained at 70 ° C.
B. The following components (10) to (14) are heated and mixed and maintained at 70 ° C.
C. B is added to A and emulsified.
D. After cooling C, the following component (15) was added and mixed to obtain a cleansing cream.
(Ingredient) (%)
(1) Paraffin wax 10.0
(2) Beeswax 3.0
(3) Vaseline 15.0
(4) Liquid paraffin 41.0
(5) Sorbitan sesquioleate 4.2
(6) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.8
(7) Hydrogenated soybean phospholipid 0.5
(8) Medu home oil * 1 1.0
(9) Methyl paraoxybenzoate 0.1
(10) Quince seed extract * 2 1.0
(11) Soybean extract * 3 1.0
(12) Mallow extract * 4 1.0
(13) GSP * 5 1.0
(14) Purified water Remaining amount (15) Perfume appropriate amount * 1 Made by Nippon Surfactant * 2 Made by Koei Kogyo * 3 Made by Maruzen Pharmaceutical * 4 Made by Maruzen Pharmaceutical * 5 Prepared in Example 1
調製したクレンジングクリームは、軽やかで滑らかな使用感を有し、メイク汚れとのなじみも良く、汚れ落ちに優れ、肌荒れや肌のくすみなどがない美しい肌にするクレンジングクリームであった。 The prepared cleansing cream was a cleansing cream that had a light and smooth feeling of use, was well-familiar with makeup stains, was excellent in removing stains, and had beautiful skin with no rough skin or dull skin.
[例6:乳液]
以下の方法により乳液を調製した。
(製法)
A.下記成分(14)〜(23)を加熱混合し、70℃に保つ。
B.下記成分(1)〜(13)を加熱混合し、70℃に保つ。
C.AにBを加えて乳化する。
D.Cを冷却後、下記成分(24)、(25)、及び(26)を加えて混合し乳液を得た。
(成分) (%)
(1)モノステアリン酸ソルビタン 0.3
(2)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.1
(3)親油型モノステアリン酸グリセリル 0.2
(4)ステアリン酸 0.5
(5)セタノール 0.5
(6)スクワラン 3.0
(7)流動パラフィン 4.0
(8)植物性スクワラン*1 0.2
(9)トリ−2−エチルヘキサン酸グリセリル 2.0
(10)ジメチルポリシロキサン 1.0
(11)水素添加大豆リン脂質 0.1
(12)ニコチン酸dl−α−トコフェロール*2 0.05
(13)パラオキシ安息香酸メチル 0.1
(14)カルボキシビニルポリマー 0.1
(15)水酸化ナトリウム 0.05
(16)グリセリン 5.0
(17)1,3−ブチレングリコール 7.0
(18)精製水 残量
(19)GPE*3 0.5
(20)GPI*4 0.5
(21)霊芝抽出物*5 2.0
(22)ヒアルロン酸ナトリウム1%水溶液*6 5.0
(23)アセチルグルタミン酸*7 0.3
(24)エチルアルコール 5.0
(25)多孔質シリカ 3.0
(26)香料 適量
*1 日光ケミカルズ社製
*2 エーザイ社製
*3 例1で調製したもの
*4 例1で調製したもの
*5 丸善製薬社製
*6 日光ケミカルズ社製
*7 協和醗酵社製
[Example 6: Latex]
An emulsion was prepared by the following method.
(Manufacturing method)
A. The following components (14) to (23) are heated and mixed and maintained at 70 ° C.
B. The following components (1) to (13) are heated and mixed and maintained at 70 ° C.
C. B is added to A and emulsified.
D. After cooling C, the following components (24), (25), and (26) were added and mixed to obtain an emulsion.
(Ingredient) (%)
(1) Sorbitan monostearate 0.3
(2) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.1
(3) Lipophilic glyceryl monostearate 0.2
(4) Stearic acid 0.5
(5) Cetanol 0.5
(6) Squalane 3.0
(7) Liquid paraffin 4.0
(8) Plant squalane * 1 0.2
(9) Glyceryl tri-2-ethylhexanoate 2.0
(10) Dimethylpolysiloxane 1.0
(11) Hydrogenated soybean phospholipid 0.1
(12) nicotinic acid dl-α-tocopherol * 2 0.05
(13) Methyl paraoxybenzoate 0.1
(14) Carboxyvinyl polymer 0.1
(15) Sodium hydroxide 0.05
(16) Glycerin 5.0
(17) 1,3-butylene glycol 7.0
(18) Purified water remaining amount (19) GPE * 3 0.5
(20) GPI * 4 0.5
(21) Reishi extract * 5 2.0
(22) Sodium hyaluronate 1% aqueous solution * 6 5.0
(23) Acetylglutamic acid * 7 0.3
(24) Ethyl alcohol 5.0
(25) Porous silica 3.0
(26) Perfume appropriate amount * 1 Nikko Chemicals * 2 Eisai * 3 Prepared in Example 1 * 4 Prepared in Example 1 * 5 Maruzen Pharmaceutical * 6 Nikko Chemicals * 7 Kyowa Hakko
[例7:乳液]
(製法)
A.下記成分(13)〜(22)を加熱混合し、70℃に保つ。
B.下記成分(1)〜(12)を加熱混合し、70℃に保つ。
C.AにBを加えて均一に乳化する。
D.Cを冷却後、下記成分(23)、(24)、(25)を加えて混合し乳液を得た。
(成分) (%)
(1)モノステアリン酸ソルビタン 0.3
(2)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.1
(3)親油型モノステアリン酸グリセリル 0.2
(4)ステアリン酸 0.5
(5)セタノール 0.5
(6)スクワラン 3.0
(7)流動パラフィン 4.0
(8)トリ−2−エチルヘキサン酸グリセリル 2.0
(9)ジメチルポリシロキサン 1.0
(10)水素添加大豆リン脂質 0.1
(11)ルチン*1 0.2
(12)パラオキシ安息香酸メチル 0.1
(13)カルボキシビニルポリマー 0.1
(14)水酸化ナトリウム 0.05
(15)グリセリン 5.0
(16)1,3−ブチレングリコール 7.0
(17)GPI*2 5.0
(18)精製水 残量
(19)酵母抽出物*3 0.5
(20)アシタバ抽出物*4 0.5
(21)ホップ抽出物*5 0.5
(22)モモ抽出物*6 0.5
(23)エチルアルコール 5.0
(24)多孔質シリカ 3.0
(25)香料 適量
*1 シグマ社製
*2 例1で調製したもの
*3 BIO−DELL社製
*4 丸善製薬社製
*5 丸善製薬社製
*6 丸善製薬社製
[Example 7: Latex]
(Manufacturing method)
A. The following components (13) to (22) are heated and mixed and maintained at 70 ° C.
B. The following components (1) to (12) are heated and mixed and maintained at 70 ° C.
C. Add B to A and emulsify uniformly.
D. After cooling C, the following components (23), (24) and (25) were added and mixed to obtain an emulsion.
(Ingredient) (%)
(1) Sorbitan monostearate 0.3
(2) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.1
(3) Lipophilic glyceryl monostearate 0.2
(4) Stearic acid 0.5
(5) Cetanol 0.5
(6) Squalane 3.0
(7) Liquid paraffin 4.0
(8) Glyceryl tri-2-ethylhexanoate 2.0
(9) Dimethylpolysiloxane 1.0
(10) Hydrogenated soybean phospholipid 0.1
(11) Rutin * 1 0.2
(12) Methyl paraoxybenzoate 0.1
(13) Carboxyvinyl polymer 0.1
(14) Sodium hydroxide 0.05
(15) Glycerin 5.0
(16) 1,3-butylene glycol 7.0
(17) GPI * 2 5.0
(18) Purified water remaining amount (19) Yeast extract * 3 0.5
(20) Ashitaba extract * 4 0.5
(21) Hop extract * 5 0.5
(22) Peach extract * 6 0.5
(23) Ethyl alcohol 5.0
(24) Porous silica 3.0
(25) Fragrance Appropriate amount * 1 Made by Sigma * 2 Made in Example 1 * 3 Made by BIO-DELL * 4 Made by Maruzen Pharmaceutical * 5 Made by Maruzen Pharmaceutical * 6 Made by Maruzen Pharmaceutical
例6及び7の調製した乳液はいずれも、滑らかでマイルドな使用感を有し、肌荒れや肌のくすみなどがない美しい肌にする乳液であった。 Each of the prepared emulsions of Examples 6 and 7 was an emulsion that had a smooth and mild use feeling and made beautiful skin without rough skin or dull skin.
[例8:パック]
(製法)
A.下記成分(1)〜(7)を混合し、70℃に加熱し溶解する。
B.下記成分(8)〜(13)を混合溶解する。
C.下記成分(14)〜(16)を混合溶解する。
D.BをAに加え、混合した後、冷却し、更にCを混合してパックを得た。
(成分) (%)
(1)ポリビニルアルコール 13.0
(2)無水ケイ酸 0.5
(3)ポリエチレングリコール 0.5
(4)メドゥホーム油*1 0.2
(5)ポリオキシプロピレン(10P.O.)
メチルグルコシド 5.0
(6)グリセリン 5.0
(7)精製水 残量
(8)茶抽出物*2 1.0
(9)ハマナス抽出物*3 1.0
(10)無水カフェイン*4 1.0
(11)GPE*5 5.0
(12)リン酸−L−アスコルビルマグネシウム*6 3.0
(13)精製水 10.0
(14)パラオキシ安息香酸エチル 0.1
(15)エチルアルコール 13.0
(16)香料 適量
*1 日本サーファクタント工業社製
*2 丸善製薬社製
*3 丸善製薬社製
*4 純正薬品工業社製
*5 例1で調製したもの
*6 日光ケミカルズ社製
[Example 8: Pack]
(Manufacturing method)
A. The following components (1) to (7) are mixed and heated to 70 ° C. to dissolve.
B. The following components (8) to (13) are mixed and dissolved.
C. The following components (14) to (16) are mixed and dissolved.
D. B was added to A, mixed and then cooled, and further C was mixed to obtain a pack.
(Ingredient) (%)
(1) Polyvinyl alcohol 13.0
(2) Silicic anhydride 0.5
(3) Polyethylene glycol 0.5
(4) Medu home oil * 1 0.2
(5) Polyoxypropylene (10 PO)
Methyl glucoside 5.0
(6) Glycerin 5.0
(7) Purified water remaining amount (8) Tea extract * 2 1.0
(9) Hermanus extract * 3 1.0
(10) Anhydrous caffeine * 4 1.0
(11) GPE * 5 5.0
(12) Phosphoric acid-L-ascorbyl magnesium * 6 3.0
(13) Purified water 10.0
(14) Ethyl paraoxybenzoate 0.1
(15) Ethyl alcohol 13.0
(16) Fragrance Appropriate amount * 1 Made by Nippon Surfactant Co., Ltd. * 2 Made by Maruzen Pharmaceutical Co., Ltd. * 3 Made by Maruzen Pharmaceutical Co., Ltd. * 4 Made by Pure Chemical Industries, Ltd. * 5 Prepared in Example 1 * 6 Made by Nikko Chemicals
調製したパックは、適度な清涼感と緊張感があり、パックした後の肌には、肌にははり感があり、肌荒れや肌のくすみなどがない美しい肌にするパックであった。 The prepared pack had an appropriate refreshing feeling and tension, and the skin after packing had a feeling of elasticity on the skin, and it was a beautiful skin with no rough skin or dull skin.
[例9:クリームファンデーション]
(製法)
A.下記成分(1)〜(11)を加熱混合し、70℃に保つ。
B.下記成分(12)〜(17)を加熱混合し、70℃に保つ。
C.AにBを加えて乳化する。
D.Cを冷却後、下記成分(18)を加えて混合しクリームファンデーションを得た。
(成分) (%)
(1)セスキオレイン酸ソルビタン 3.0
(2)自己乳化型モノステアリン酸グリセリル 2.0
(3)ステアリン酸アルミニウム 0.5
(4)セレシンワックス 5.0
(5)スクワラン 10.0
(6)流動パラフィン 15.0
(7)ワセリン 5.0
(8)酸化チタン 8.0
(9)タルク 4.0
(10)着色顔料 適量
(11)パラオキシ安息香酸メチル 0.05
(12)プロピレングリコール 5.0
(13)キンギンカ抽出物*1 1.0
(14)シラカバ抽出物*2 1.0
(15)GPI*3 0.1
(16)GPE*4 0.1
(17)精製水 残量
(18)香料 適量
*1 長岡香料社製
*2 丸善製薬社製
*3 例1で調製したもの
*4 例1で調製したもの
[Example 9: Cream foundation]
(Manufacturing method)
A. The following components (1) to (11) are heated and mixed and maintained at 70 ° C.
B. The following components (12) to (17) are heated and mixed and maintained at 70 ° C.
C. B is added to A and emulsified.
D. After cooling C, the following component (18) was added and mixed to obtain a cream foundation.
(Ingredient) (%)
(1) Sorbitan sesquioleate 3.0
(2) Self-emulsifying glyceryl monostearate 2.0
(3) Aluminum stearate 0.5
(4) Ceresin wax 5.0
(5) Squalane 10.0
(6) Liquid paraffin 15.0
(7) Vaseline 5.0
(8) Titanium oxide 8.0
(9) Talc 4.0
(10) Coloring pigment appropriate amount (11) Methyl paraoxybenzoate 0.05
(12) Propylene glycol 5.0
(13) Kinginga extract * 1 1.0
(14) Birch extract * 2 1.0
(15) GPI * 3 0.1
(16) GPE * 4 0.1
(17) Purified water Remaining amount (18) Fragrance Appropriate amount * 1 Nagaoka Fragrance Co., Ltd. * 2 Maruzen Pharmaceutical Co., Ltd. * 3 Prepared in Example 1 * 4 Prepared in Example 1
[例10:リキッドファンデーション]
(製法)
A.下記成分(1)〜(9)を混合溶解する。
B.Aに下記成分(20)〜(25)を加え、均一に混合し、70℃に保つ。
C.下記成分(10)〜(19)を均一に溶解し、70℃に保つ。
D.CにBを添加して乳化する。
E.Dを冷却後、下記成分(26)を加えて混合しリキッドファンデーションを得た。
(成分) (%)
(1)液状ラノリン 2.0
(2)流動パラフィン 5.0
(3)ステアリン酸 2.0
(4)セタノール 1.0
(5)自己乳化型モノステアリン酸グリセリル 1.0
(6)パラメトキシケイ皮酸−2−エチルヘキシル 8.0
(7)4−tert−ブチル−4’−メトキシ
ジベンゾイルメタン 2.0
(8)パルミチン酸レチノール*1 0.2
(9)パラオキシ安息香酸メチル 0.1
(10)グリセリン 5.0
(11)トリエタノールアミン 1.0
(12)カルボキシメチルセルロース 0.2
(13)ベントナイト 0.5
(14)シラカバ抽出液*2 5.0
(15)精製水 残量
(16)マンニトール*3 0.1
(17)GSP*4 1.0
(18)アスパラガス抽出物*5 0.5
(19)甘草抽出物*6 0.5
(20)酸化チタン 6.0
(21)微粒子酸化チタン 2.0
(22)微粒子酸化亜鉛 5.0
(23)マイカ 2.0
(24)タルク 4.0
(25)着色顔料 4.0
(26)香料 適量
*1 日本ロシュ社製
*2 丸善製薬社製
*3 シグマ社製
*4 例1で調製したもの
*5 丸善製薬社製
*6 丸善製薬社製
[Example 10: Liquid foundation]
(Manufacturing method)
A. The following components (1) to (9) are mixed and dissolved.
B. The following components (20) to (25) are added to A, mixed uniformly, and kept at 70 ° C.
C. The following components (10) to (19) are uniformly dissolved and maintained at 70 ° C.
D. B is added to C and emulsified.
E. After cooling D, the following component (26) was added and mixed to obtain a liquid foundation.
(Ingredient) (%)
(1) Liquid lanolin 2.0
(2) Liquid paraffin 5.0
(3) Stearic acid 2.0
(4) Cetanol 1.0
(5) Self-emulsifying glyceryl monostearate 1.0
(6) Paramethoxycinnamic acid-2-ethylhexyl 8.0
(7) 4-tert-butyl-4′-methoxy dibenzoylmethane 2.0
(8) Retinol palmitate * 1 0.2
(9) Methyl paraoxybenzoate 0.1
(10) Glycerin 5.0
(11) Triethanolamine 1.0
(12) Carboxymethylcellulose 0.2
(13) Bentonite 0.5
(14) Birch extract * 2 5.0
(15) Purified water remaining amount (16) Mannitol * 3 0.1
(17) GSP * 4 1.0
(18) Asparagus extract * 5 0.5
(19) Licorice extract * 6 0.5
(20) Titanium oxide 6.0
(21) Fine particle titanium oxide 2.0
(22) Fine zinc oxide 5.0
(23) Mica 2.0
(24) Talc 4.0
(25) Color pigment 4.0
(26) Perfume appropriate amount * 1 Nippon Roche * 2 Maruzen Pharmaceutical * 3 Sigma * 4 Prepared in Example 1 * 5 Maruzen Pharmaceutical * 6 Maruzen Pharmaceutical
調製した例9及び10は、コクのある滑らかな使用感を有し、均一で美しい仕上がりが得られ、肌荒れや肌のくすみなどがない美しい肌にするクリームファンデーション、リキッドファンデーションであった。 The prepared Examples 9 and 10 were cream foundations and liquid foundations having a smooth and smooth feeling of use, a uniform and beautiful finish, and a beautiful skin without rough skin and dull skin.
[例11:日焼け止め乳液]
(製法)
A.下記成分(1)〜(10)を混合し、70℃に保つ。
B.下記成分(11)〜(15)を混合し、70℃に保つ。
C.AにBを添加して、均一に乳化する。
D.Cを冷却後、下記成分(16)〜(19)を加えて混合し日焼け止め乳液を得た。
(成分) (%)
(1)ポリオキシアルキレン変性オルガノポリシロキサン 1.0
(2)ジメチルポリシロキサン 5.0
(3)オクタメチルシクロテトラシロキサン 20.0
(4)イソノナン酸イソトリデシル 5.0
(5)パラメトキシケイ皮酸−2−エチルヘキシル 5.0
(6)パラオキシ安息香酸メチル 0.1
(7)シリコーン処理微粒子酸化チタン 10.0
(8)シリコーン処理微粒子酸化亜鉛 10.0
(9)ポリスチレン末 3.0
(10)トリメチルシロキシケイ酸 0.5
(11)ジプロピレングリコール 3.0
(12)エチルアルコール 10.0
(13)GPE*1 1.0
(14)食塩 0.2
(15)精製水 残量
(16)β−カロチン*2 0.01
(17)カミツレ抽出物*3 1.0
(18)ワレモコウ抽出物*4 1.0
(19)香料 適量
*1 例1で調製したもの
*2 シグマ社製
*3 丸善製薬社製
*4 丸善製薬社製
[Example 11: Sunscreen emulsion]
(Manufacturing method)
A. The following components (1) to (10) are mixed and maintained at 70 ° C.
B. The following components (11) to (15) are mixed and maintained at 70 ° C.
C. Add B to A and emulsify uniformly.
D. After cooling C, the following components (16) to (19) were added and mixed to obtain a sunscreen emulsion.
(Ingredient) (%)
(1) Polyoxyalkylene-modified organopolysiloxane 1.0
(2) Dimethylpolysiloxane 5.0
(3) Octamethylcyclotetrasiloxane 20.0
(4) Isotridecyl isononanoate 5.0
(5) Paramethoxycinnamic acid-2-ethylhexyl 5.0
(6) Methyl paraoxybenzoate 0.1
(7) Silicone-treated fine particle titanium oxide 10.0
(8) Silicone-treated fine particle zinc oxide 10.0
(9) Polystyrene powder 3.0
(10) Trimethylsiloxysilicate 0.5
(11) Dipropylene glycol 3.0
(12) Ethyl alcohol 10.0
(13) GPE * 1 1.0
(14) Salt 0.2
(15) Purified water remaining amount (16) β-carotene * 2 0.01
(17) Chamomile extract * 3 1.0
(18) Warmoko extract * 4 1.0
(19) Perfume Appropriate amount * 1 Prepared in Example 1 * 2 Sigma Co., Ltd. * 3 Maruzen Pharmaceutical Co., Ltd. * 4 Maruzen Pharmaceutical Co., Ltd.
例11の日焼け止め乳液は、べたつきのない滑らかな使用感を有し、紫外線から肌を守るとともに、肌荒れや肌のくすみなどのない美しい肌にする日焼け止め乳液であった。 The sunscreen emulsion of Example 11 was a sunscreen emulsion that had a smooth use feeling without stickiness, protected the skin from ultraviolet rays, and made beautiful skin free from rough skin and dull skin.
本発明によれば、新規な細胞賦活剤及び老化防止用皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the novel cell activator and the skin external preparation for anti-aging can be provided.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008047445A JP5198899B2 (en) | 2008-02-28 | 2008-02-28 | Cell activator and anti-aging skin external preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008047445A JP5198899B2 (en) | 2008-02-28 | 2008-02-28 | Cell activator and anti-aging skin external preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009203190A true JP2009203190A (en) | 2009-09-10 |
JP5198899B2 JP5198899B2 (en) | 2013-05-15 |
Family
ID=41145804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008047445A Expired - Fee Related JP5198899B2 (en) | 2008-02-28 | 2008-02-28 | Cell activator and anti-aging skin external preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5198899B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009269851A (en) * | 2008-05-07 | 2009-11-19 | Nikko Chemical Co Ltd | Inhibitor of prostaglandin e2 production and its utilization |
JP2013203731A (en) * | 2012-03-29 | 2013-10-07 | Nof Corp | Hyaluronic acid production promoter |
JP2013203729A (en) * | 2012-03-29 | 2013-10-07 | Nof Corp | Collagen production promoter |
JP2014501733A (en) * | 2010-11-30 | 2014-01-23 | リチェルファルマ ソシエタ レスポンサビリタ リミタータ | Topical composition for preserving or restoring the intact state of the mucosa |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01287091A (en) * | 1988-01-20 | 1989-11-17 | Q P Corp | Phospholipid derivative and cosmetic containing the same |
JPH07506348A (en) * | 1992-03-30 | 1995-07-13 | フレイラー エス.エー.ファーマスィーティカル ファイン ケミカルズ | Cosmetic or pharmaceutical compositions containing deacylated glycerophospholipids suitable for topical use |
JPH11100320A (en) * | 1997-09-29 | 1999-04-13 | Risuburan:Kk | Preparation for external use for skin |
JP2000226308A (en) * | 1998-12-04 | 2000-08-15 | Shiseido Co Ltd | Agent for stimulating production of laminin in epidermal cell |
JP2003531833A (en) * | 2000-04-12 | 2003-10-28 | ビトプ アクチェンゲゼルシャフト フューア ビオテヒニシェ オプティミールング | Use of compatible solutes as materials with free radical scavenging properties |
JP2004506676A (en) * | 2000-08-18 | 2004-03-04 | ビトプ アクチェンゲゼルシャフト フューア ビオテヒニシェ オプティミールング | Formulations for cosmetics |
JP2004536838A (en) * | 2001-07-07 | 2004-12-09 | バイヤースドルフ・アクチエンゲゼルシヤフト | Cosmetic and dermatological preparations containing osmolyte for the treatment and effective prevention of dry skin and other negative changes in the physiological homeostasis of healthy skin |
JP2007169242A (en) * | 2005-12-26 | 2007-07-05 | Toyo Shinyaku:Kk | Cosmetic |
-
2008
- 2008-02-28 JP JP2008047445A patent/JP5198899B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01287091A (en) * | 1988-01-20 | 1989-11-17 | Q P Corp | Phospholipid derivative and cosmetic containing the same |
JPH07506348A (en) * | 1992-03-30 | 1995-07-13 | フレイラー エス.エー.ファーマスィーティカル ファイン ケミカルズ | Cosmetic or pharmaceutical compositions containing deacylated glycerophospholipids suitable for topical use |
JPH11100320A (en) * | 1997-09-29 | 1999-04-13 | Risuburan:Kk | Preparation for external use for skin |
JP2000226308A (en) * | 1998-12-04 | 2000-08-15 | Shiseido Co Ltd | Agent for stimulating production of laminin in epidermal cell |
JP2003531833A (en) * | 2000-04-12 | 2003-10-28 | ビトプ アクチェンゲゼルシャフト フューア ビオテヒニシェ オプティミールング | Use of compatible solutes as materials with free radical scavenging properties |
JP2004506676A (en) * | 2000-08-18 | 2004-03-04 | ビトプ アクチェンゲゼルシャフト フューア ビオテヒニシェ オプティミールング | Formulations for cosmetics |
JP2004536838A (en) * | 2001-07-07 | 2004-12-09 | バイヤースドルフ・アクチエンゲゼルシヤフト | Cosmetic and dermatological preparations containing osmolyte for the treatment and effective prevention of dry skin and other negative changes in the physiological homeostasis of healthy skin |
JP2007169242A (en) * | 2005-12-26 | 2007-07-05 | Toyo Shinyaku:Kk | Cosmetic |
Non-Patent Citations (4)
Title |
---|
CSNC200802180025; 新化粧品ハンドブック , 20061030, 第518-522頁, 日光ケミカルズ株式会社 * |
CSNC201100675040; 辻田 隆広: 'ホスホリパーゼA' 日本臨床(増刊)高脂血症 (上) 第59巻, 第209-213頁, 株式会社日本臨牀社 * |
JPN6012047453; 新化粧品ハンドブック , 20061030, 第518-522頁, 日光ケミカルズ株式会社 * |
JPN6012047455; 辻田 隆広: 'ホスホリパーゼA' 日本臨床(増刊)高脂血症 (上) 第59巻, 第209-213頁, 株式会社日本臨牀社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009269851A (en) * | 2008-05-07 | 2009-11-19 | Nikko Chemical Co Ltd | Inhibitor of prostaglandin e2 production and its utilization |
JP2014501733A (en) * | 2010-11-30 | 2014-01-23 | リチェルファルマ ソシエタ レスポンサビリタ リミタータ | Topical composition for preserving or restoring the intact state of the mucosa |
JP2013203731A (en) * | 2012-03-29 | 2013-10-07 | Nof Corp | Hyaluronic acid production promoter |
JP2013203729A (en) * | 2012-03-29 | 2013-10-07 | Nof Corp | Collagen production promoter |
Also Published As
Publication number | Publication date |
---|---|
JP5198899B2 (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4111856B2 (en) | Stabilized ascorbic acid derivatives | |
JP6857359B2 (en) | New sugar derivative gelling agent | |
JP2005220084A (en) | Acerola seed extract-containing composition | |
JP4091824B2 (en) | Skin preparation | |
JP2004210699A (en) | Cosmetic composition | |
JP2019038754A (en) | Skin external preparation | |
JP2003048846A (en) | Collagenase inhibitor and antiaging cosmetic | |
JP3770588B2 (en) | Topical skin preparation | |
JP2008239545A (en) | Elastase deactivator | |
JP5198899B2 (en) | Cell activator and anti-aging skin external preparation | |
JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
JP5530058B2 (en) | Aqueous preparation with stabilized carotenoids | |
JP2007126444A (en) | Skin care preparation | |
JP5420848B2 (en) | Whitening agent and skin external preparation for whitening | |
JP2002332224A (en) | Anti-ageing skin care preparation and anti-ageing skin care preparation composition | |
JP2011173825A (en) | Ascorbic acid derivative | |
JP2002275018A (en) | Skin care preparation | |
JP2005306867A (en) | External preparation for skin containing inositol derivative and cosmetic | |
JP2005247826A (en) | Decorin production-promoting agent and skin care preparation for external use containing the same | |
JP2003155221A (en) | Skin care preparation | |
JP2011042613A (en) | Anti-aging skin care preparation and anti-aging cosmetic | |
JP2010150173A (en) | Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation | |
JP2009203192A (en) | Involucrin production promotor, and skin roughness-preventing or improving preparation for external use | |
JP4548831B2 (en) | Hydrogenated retinoid or hydrogenated retinoid derivative and use thereof | |
JP2005089427A (en) | Skin care preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100730 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120201 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120911 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121031 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130115 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130207 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160215 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5198899 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |